Literature DB >> 15041039

Autoimmune diabetes is blocked in Stat4-deficient mice.

Zandong Yang1, Meng Chen, Justin D Ellett, Lawrence B Fialkow, Jeffrey D Carter, Marcia McDuffie, Jerry L Nadler.   

Abstract

Signal transducers and activators of transcription (STAT) proteins are activated in response to many cytokines, growth factors and hormones. STAT4 mediates IL-12 signaling and regulates T helper 1 (Th1) cell differentiation. Both IL-12 and Th1 cell activation participate in the development of autoimmune diabetes. In this study, we investigated the role of STAT4 in autoimmune diabetes. We crossbred Stat4 deficient (Stat4-/-) mice with nonobese diabetic (NOD) mice to generate the Stat4-/- NOD model. In Stat4-/- NOD mice, serum levels of both IFN-gamma and IL-2 were significantly reduced as compared to the controls. Insulin secretion in pancreatic islets was preserved in Stat4-/- NOD mice. Significantly, disruption of Stat4 activation completely prevented the development of spontaneous diabetes in NOD mice. This study reveals the important role of STAT4 in autoimmune diabetes pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15041039     DOI: 10.1016/j.jaut.2003.08.006

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  31 in total

1.  Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.

Authors:  Swarup K Chakrabarti; Yeshao Wen; Anca D Dobrian; Banumathi K Cole; Qian Ma; Hong Pei; Michael D Williams; Melissa H Bevard; George E Vandenhoff; Susanna R Keller; Jiali Gu; Jerry L Nadler
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

Review 2.  Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease.

Authors:  Y Imai; A D Dobrian; J R Weaver; M J Butcher; B K Cole; E V Galkina; M A Morris; D A Taylor-Fishwick; J L Nadler
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

Review 3.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

4.  STAT4 polymorphisms and diabetes risk: a meta-analysis with 18931 patients and 23833 controls.

Authors:  Jian Yi; Xin Fang; Youyun Wan; Juan Wei; Jianjun Huang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  12/15-Lipoxygenase signaling in the endoplasmic reticulum stress response.

Authors:  Banumathi K Cole; Norine S Kuhn; Shamina M Green-Mitchell; Kendall A Leone; Rebekah M Raab; Jerry L Nadler; Swarup K Chakrabarti
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-03       Impact factor: 4.310

6.  Production and function of IL-12 in islets and beta cells.

Authors:  D A Taylor-Fishwick; J R Weaver; W Grzesik; S Chakrabarti; S Green-Mitchell; Y Imai; N Kuhn; J L Nadler
Journal:  Diabetologia       Date:  2012-10-03       Impact factor: 10.122

7.  STAT4 deficiency reduces the development of atherosclerosis in mice.

Authors:  Parésa L Taghavie-Moghadam; Breanne N Gjurich; Rukhsana Jabeen; Purna Krishnamurthy; Mark H Kaplan; Anca D Dobrian; Jerry L Nadler; Elena V Galkina
Journal:  Atherosclerosis       Date:  2015-09-04       Impact factor: 5.162

8.  Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.

Authors:  Ivan V Litvinov; Brendan Cordeiro; Simon Fredholm; Niels Ødum; Hanieh Zargham; Yuanshen Huang; Youwen Zhou; Kevin Pehr; Thomas S Kupper; Anders Woetmann; Denis Sasseville
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

Authors:  David Bending; Hugo De la Peña; Marc Veldhoen; Jenny M Phillips; Catherine Uyttenhove; Brigitta Stockinger; Anne Cooke
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

10.  T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.

Authors:  Jonathan H Esensten; Michael R Lee; Laurie H Glimcher; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.